I’m really excited about the prospect of nanoparticles as drug carriers. This is not simply because it represents another medium for drug delivery, but because it represents a whole new technology itself, nanotechnology.
Furthermore, engineering of FN-EDB-targeted nanoparticles (NPs) could enable imaging/diagnosis and local delivery of payloads to plaques.Methods: The amount of FN-EDB in human atherosclerotic and normal arteries (ages: 40 to 85 years) was assessed by histological staining and quantification using ...
In this approach, MNPs, primarily iron oxide nanoparticles, are incorporated into target cells to enable their attraction by a magnet placed beneath the culture plates. Magnets positioned on the underside of the culture plates provide the magnetic force necessary for this process. Cells can then be...
The cytotoxic, apoptotic and necrotic effects of these nanoparticles in the MDA 231 human breast cancer cell, the A549 human lung cancer cell and the L929 fibroblast cell lines were also investigated.doi:10.3109/21691401.2015.1115409Kilicay, Ebru...
Biosynthesis of copper oxide nanoparticles mediated Annona muricata as cytotoxic and apoptosis inducer factor in breast cancer cell lines. Scientific Reports, 12(1):16165. https://doi.org/10.1038/S41598-022-20360-Y Article Google Scholar Mohammed MKA, Ahmed DS, Mohammad MR, 2019. Studying ...
The father of Nanotechnology is Heinrich Rohrer. He was born on 6thJune 1933 and died on 16thMay 2013 in Switzerland. He is an employer in IBM and he got a Nobel prize in Physics. Some of the nanoparticles manufacturer companies are Adnano Technologies Private Limited in Majjigenahalli, Adva...
Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery Jinxin Li Honghui Wu Pengxu Qian Nature Communications(2024) Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier ...
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your perso...
Virus-like drug conjugates (VDCs) are a form of drug conjugates that use viral capsids designed as non-infectious protein nanoparticles (virus-like particles (VLPs)) as efficient delivery vehicles. Fig. 14. Virus-Like Drug Conjugates (VDC), Source: Aura Website Aura employs human papillomavirus...
First a background is given on the use of nanoparticles to co-deliver gene-silencing RNA and drug to cells. Subsequently, a brief background is given on drug delivery systems for local administration. This is followed by a review and discussion of literature on local co-administration of RNA...